Catalent
CTLT
#1496
Rank
A$18.42 B
Marketcap
$101.53
Share price
0.00%
Change (1 day)
57.19%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total debt

Total debt on the balance sheet as of September 2024 : A$7.91 Billion

According to Catalent's latest financial reports the company's total debt is A$7.91 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Catalent - Total debt on balance sheet (from 2013 to 2024)

Total debt by year

Year Total debt Change
2023-06-30A$7.34 B19.82%
2022-06-30A$6.12 B41.36%
2021-06-30A$4.33 B-1.79%
2020-06-30A$4.41 B4.73%
2019-06-30A$4.21 B14.65%
2018-06-30A$3.67 B35.84%
2017-06-30A$2.70 B8.65%
2016-06-30A$2.49 B1.61%
2015-06-30A$2.45 B-14.84%
2014-06-30A$2.87 B-2.26%
2013-06-30A$2.94 B12.4%
2012-06-30A$2.62 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$61.02 M-99.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.53 B-93.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.91 B 25.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.35 B-95.47%๐Ÿ‡บ๐Ÿ‡ธ USA